The shares of Upstart Holdings Inc (NASDAQ: UPST) just recently received a $40 price target from FBN Securities November 8, 2025
MyMD Pharmaceuticals Enrolls First Client in Stage 2 Medical Trial of MYMD-1 as a Therapy for Delaying Aging and also Extending Healthy And Balanced Lifespan November 9, 2025
